“Cytokine-Driven Immunopathogenesis of Psoriasis: Clinical Therapeutic Targets and Future Immunologic Directions” (2026) International Journal of Pharmaceutical and Healthcare Innovation, 3(2), pp. 903–923. doi:10.62752/ijphi.v3i2.243.